IDEXX Laboratories (IDXX) Stock Forecast & Price Target $635.40 -1.94 (-0.30%) Closing price 10/17/2025 04:00 PM EasternExtended Trading$636.00 +0.60 (+0.09%) As of 10/17/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IDEXX Laboratories - Analysts' Recommendations and Stock Price Forecast (2025) How MarketBeat Calculates Price Target and Consensus Rating Consensus Rating Moderate BuyBased on 12 Analyst RatingsSell0Hold4Buy8 Based on 12 Wall Street analysts who have issued ratings for IDEXX Laboratories in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 12 analysts, 4 have given a hold rating, 7 have given a buy rating, and 1 has given a strong buy rating for IDXX. Consensus Price Target $656.503.32% Upside According to the 12 analysts' twelve-month price targets for IDEXX Laboratories, the average price target is $656.50. The highest price target for IDXX is $785.00, while the lowest price target for IDXX is $520.00. The average price target represents a forecasted upside of 3.32% from the current price of $635.40. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Get the Latest News and Ratings for IDXX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for IDEXX Laboratories and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IDXX Analyst Ratings Over TimeTypeCurrent Forecast10/18/24 to 10/18/251 Month Ago9/18/24 to 9/18/253 Months Ago7/20/24 to 7/20/251 Year Ago10/19/23 to 10/18/24Strong Buy1 Strong Buy rating(s)1 Strong Buy rating(s)1 Strong Buy rating(s)0 Strong Buy rating(s)Buy7 Buy rating(s)6 Buy rating(s)6 Buy rating(s)7 Buy rating(s)Hold4 Hold rating(s)3 Hold rating(s)3 Hold rating(s)2 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price Target$656.50$649.44$560.33$574.13Forecasted Upside3.32% Upside-0.93% Downside8.89% Upside25.43% UpsideConsensus RatingModerate BuyModerate BuyModerate BuyModerate Buy IDXX Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History IDXX Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table IDEXX Laboratories Stock vs. The CompetitionTypeIDEXX LaboratoriesMedical CompaniesS&P 500Consensus Rating Score 2.75 2.33 2.52Consensus RatingModerate BuyHoldModerate BuyPredicted Upside3.32% Upside1,357.67% Upside13.60% UpsideNews Sentiment RatingVery Positive NewsSee Recent IDXX NewsNeutral NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalystActionRatingPrice TargetReport Date Upside/DownsideDetails10/8/2025Weiss Ratings0 of 5 stars Reiterated RatingBuy (B-)10/1/2025UBS Group4 of 5 starsAndrea Alfonso Not RatedInitiated CoverageNeutral$720.00+12.70%8/15/2025Morgan Stanley3 of 5 starsErin Wright5 of 5 starsBoost TargetOverweight$722.00 ➝ $765.00+16.98%8/11/2025Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDavid WestenbergSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingNeutral$510.00 ➝ $700.00+6.37%8/5/2025BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Boost TargetBuy$545.00 ➝ $785.00+17.88%8/4/2025Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Set Target$640.00-0.30%8/4/2025JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingChris SchottSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetOverweight$550.00 ➝ $675.00-1.14%7/17/2025Leerink PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDaniel ClarkSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetOutperform$580.00 ➝ $600.00+15.47%7/1/2025Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Initiated CoverageBuy$625.00+16.53%2/4/2025BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBalaji PrasadSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetOverweight$481.00 ➝ $520.00+10.86% Get the Latest News and Ratings for IDXX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for IDEXX Laboratories and its competitors with MarketBeat's FREE daily newsletter. 2/4/2025Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingMichael RyskinSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetNeutral$475.00 ➝ $535.00+14.06%12/2/2024Leerink PartnrsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingD. ClarkSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingUpgradeStrong-Buy4/9/2024William BlairSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Reiterated RatingOutperform1/17/2024The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Boost TargetBuy$500.00 ➝ $650.00+25.68%12/7/2023BNP ParibasSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Initiated CoverageOutperform$602.00+15.42%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 11:18 PM ET. Should I Buy IDEXX Laboratories Stock? IDXX Pros and Cons Explained These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, October 17, 2025. Please send any questions or comments about these IDEXX Laboratories pros and cons to contact@marketbeat.com. IDEXX Laboratories Bull Case Here are some ways that investors could benefit from investing in IDEXX Laboratories, Inc.: The current stock price is around $633, reflecting a strong performance in the market and indicating investor confidence. IDEXX Laboratories, Inc. reported earnings per share (EPS) of $3.63 for the latest quarter, exceeding analysts' expectations, which demonstrates robust financial health and growth potential. The company has a high return on equity of 64.42%, suggesting effective management and a strong ability to generate profits from shareholders' equity. Recent revenue growth of 10.6% compared to the same quarter last year indicates a positive trend in sales and market demand for its products. Analysts have a consensus rating of "Moderate Buy" with an average price target of $656.50, suggesting potential for price appreciation in the near future. IDEXX Laboratories Bear Case Investors should be bearish about investing in IDEXX Laboratories, Inc. for these reasons: The stock has a high P/E ratio of 53.03, which may indicate that it is overvalued compared to its earnings, potentially leading to a price correction. Insider selling has been significant, with a total of 54,057 shares sold recently, which could signal a lack of confidence from those closest to the company. The beta of 1.58 suggests that the stock is more volatile than the market, which could lead to larger price swings and increased risk for investors. Despite recent growth, the P/E/G ratio of 4.10 indicates that the stock may not be growing fast enough to justify its high price relative to its earnings growth. Analysts have mixed ratings, with some downgrading the stock from "strong-buy" to "buy," indicating uncertainty about its future performance. IDXX Forecast - Frequently Asked Questions What is IDEXX Laboratories' forecast for 2025? According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for IDEXX Laboratories is $656.50, with a high forecast of $785.00 and a low forecast of $520.00. Should I buy or sell IDEXX Laboratories stock right now? 12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for IDEXX Laboratories in the last twelve months. There are currently 4 hold ratings, 7 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" IDXX shares. Does IDEXX Laboratories's stock price have much upside? According to analysts, IDEXX Laboratories's stock has a predicted upside of 3.32% based on their 12-month stock forecasts. What analysts cover IDEXX Laboratories? IDEXX Laboratories has been rated by research analysts at BTIG Research, JPMorgan Chase & Co., Morgan Stanley, Piper Sandler, Stifel Nicolaus, UBS Group, and Weiss Ratings in the past 90 days. Do Wall Street analysts like IDEXX Laboratories more than its competitors? Analysts like IDEXX Laboratories more than other "medical" companies. The consensus rating for IDEXX Laboratories is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how IDXX compares to other companies. Stock Forecasts and Research Tools Related Companies NVST Stock Forecast ZTS Stock Forecast ISRG Stock Forecast BSX Stock Forecast SYK Stock Forecast MDT Stock Forecast BDX Stock Forecast EW Stock Forecast RMD Stock Forecast DXCM Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NASDAQ:IDXX) was last updated on 10/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredBuy alert: Move $1,000 before Tesla’s Optimus launchElon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredThe “smart money” is piling into one AI power company.Expert Reveals: The #1 Energy Play for 2025 "We're Entering the Greatest Energy Bull Market Since the Indus...Brownstone Research | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredElon’s Optimus to mint new “Musk Millionaires” as soon as Oct 23???Elon Musk may be set to create more "Musk Millionaires" as soon as October 23rd… Because on that day, he's exp...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IDEXX Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IDEXX Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IDXX Stock Alerts